Location History:
- Sceauz, FR (2013)
- Sceaux, FR (2017 - 2024)
Company Filing History:
2 out of 2,370 
2 out of 1,154 
1 out of 1 Years Active: 2013-2024
Title: Luc Cynober: Innovator in Diabetes Treatment
Introduction
Luc Cynober is a notable inventor based in Sceaux, France. He has made significant contributions to the field of medical science, particularly in the treatment of diabetes and metabolic syndrome. With a total of 5 patents to his name, Cynober's work focuses on innovative compositions that utilize specific amino acids for therapeutic purposes.
Latest Patents
Cynober's latest patents include compositions comprising citrulline and leucine, which are aimed at treating diabetes and metabolic syndrome. These compositions contain citrulline and leucine or their metabolites, such as hydroxyisocaproic acid (HICA) or beta-hydroxy-beta-methylbutyrate (HMB). The formulations are designed to provide a synergistic effect, making them effective in methods for treating pre-diabetes, metabolic syndrome, and diabetes.
Career Highlights
Throughout his career, Luc Cynober has worked with prominent companies in the food and nutrition sector, including Nestec S.A. and Société des Produits Nestlé S.A. His expertise in amino acid research has positioned him as a key figure in developing nutritional solutions for metabolic disorders.
Collaborations
Cynober has collaborated with various professionals in his field, including Christophe Moinard and Denis Breuille. These partnerships have contributed to the advancement of his research and the successful development of his patented compositions.
Conclusion
Luc Cynober's innovative work in the field of diabetes treatment showcases his dedication to improving health outcomes through scientific research. His contributions continue to influence the development of effective nutritional therapies for metabolic conditions.